

HY-113914 · 10 mM * 1 mL in DMSO
MedChemExpress · Cat: HY-113914
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/9-ing-41.html
Description
9-ING-41 Elraglusib is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3? GSK-3? inhibitor with an IC50 of 0.71 ?M. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents.







